This article, published in Morbidity and Mortality Weekly Report, summarizes the Advisory Committee on Immunization Practices review of post-marketing safety surveillance data on RotaTeq®, the rotavirus vaccine by Merck & Co., Inc. The …

This manual provides a review of current knowledge related to the safety of rotavirus vaccine and suggests approaches for monitoring safety after vaccine introduction in a country.

Investigators developed a model using epidemiological evidence, country-specific cost estimates, and vaccine efficacy data to estimate the cost-effectiveness of rotavirus vaccination and determined that it would reduce health care expenses and …

International data show a low-level increased risk of intussusception associated with rotavirus vaccination. This article, published in the Pediatric Infectious Disease Journal, reports on a study that compared potential vaccine-associated …

This study, published in the Journal of Tropical Medicine and Hygiene, evaluated the feasibility of antibody markers as indicators of infections with water-borne pathogens in order to determine the epidemiology of water-borne diarrheal …

This report, published in Morbidity and Mortality Weekly Report, provides background on the development of RotaTeq®, Merck's vaccine against rotavirus, and recommendations for its use in the prevention of rotavirus through immunization.

This article, published in Biologics: Targets & Therapy, provides a comprehensive review of current rotavirus vaccines, summarizing studies on their safety and efficacy, as well as special considerations that may inform future research studies. …

This report provides an overview of the symposium’s sessions, presentations, and discussions.

This report provides an overview of the symposium’s sessions, presentations, and discussions.

Several vaccines that have come to market, including the rotavirus, pneumococcal conjugate, and human papillomavirus vaccines, have the potential to bring large public health benefits to developing countries. This eight-page policy brief explains …

This article, published in Vaccine, projects the cost-effectiveness and health impact of rotavirus vaccines in countries eligible for support from the GAVI Alliance. The authors used a decision-analytic model to project the health outcomes and …

The authors of this article, published in Vaccine, determined the impact and cost-effectiveness of pneumococcal and rotavirus vaccination programs among children younge than five years of age in Uganda from the public health system perspective. They …

The authors of this article, published in Clinical Infectious Diseases, aimed to determine the potential impact and cost-effectiveness of a national rotavirus vaccination program in India. They compared the national rotavirus disease and cost burden …

This article, published in Human Vaccines, describes the projected effectiveness of RotaTeq®, which is an oral pentavalent rotavirus vaccine (RV5), against rotavirus gastroenteritis (RGE)-related hospitalizations and deaths in six Asian …

This editorial, published in the New England Journal of Medicine, summarizes findings from successful safety and efficacy studies of Rotarix® and RotaTeq® vaccines, while also emphasizing the need for clinical trials to evaluate the …

This fact sheet describes how PATH developed a low-cost and straightforward technology for protecting aluminum-adjuvanted liquid vaccines from the irreversible damage that results from freezing. Many current vaccines of importance to global …

This fact sheet provides a snapshot of PATH's programs that tackle the leading causes of childhood illness and death: pneumonia, diarrheal disease, and malaria. It profiles PATH's work on new and innovative vaccines, medicines, diagnostics, and …

This fact sheet provides an overview of PATH's work, including vaccine development and introduction, in protecting children from diarrheal disease.

These pre-formatted PubMed searches will retrieve journal citations and available abstracts that address relevant issues related to rotavirus. Documents may be ordered through Loansome Doc if you have established an agreement with a participating …

This special supplement of the Pediatric Infectious Disease Journal presents a collection of studies on the impact of rotavirus vaccines. The data demonstrate dramatic and rapid reductions in childhood hospitalizations in several countries after …

The meeting report outlines the committee's recommendations for introduction of RotaTeq® into the routine US immunization schedule and provides guidance on addressing special circumstances in relation to administration of the vaccine. The …

This article, published in the Bulletin of the World Health Organization, examines whether the reduced prices for rotavirus vaccine are affordable enough to facilitate access to the vaccine where it is most needed. The study points to the rotavirus …

This study, published in The Journal of Infectious Diseases, shows a dramatic reduction of acute gastroenteritis hospitalizations in the United States following the 2006 introduction of the RotaTeq® rotavirus vaccine. The study gathered …

This article, published in PLOS Medicine, reports on a study that analyzed the benefits and risks of relaxing the vaccine dosing age restrictions for rotavirus vaccines and concluded that the lives of nearly 50,000 additional children in low- and …

Lack of information on both the price and the different product characteristics of vaccines limits countries’ ability to operate affordable and effective immunization programs. This report aims to remedy some of the existing knowledge gaps by …